Founder

Kemp Dolliver, CFA

Cherrystone Hill Research

Equity Bottom-Up

Biosensors International / Equity Bottom-Up

<p style="text-align: justify;">Biosensors' Q3FY16 results referenced by Travis Lundy <a href="https://www.smartkarma.com/insights/biosensors-docs-out-deal-really-on" target="_blank" data-smartkarma-citation="insights:2915">Biosensors: Docs Out Deal Really On</a> don't help any arguments for a higher valuation (nine month results):</p><ol>
<li>Revenue -18% with product revenue -15% and licensing revenue -48%</li>
<li>Operating income -15% with across-the-board expense reductions mitigating the damage</li>
<li>Profit before exceptional items and charges -7% (mitigated by F/X gains and lower interest expense)</li>
</ol><p style="text-align: justify;">Fundamentally, the company continues to struggle with the usual intense competition with a…</p>

Biosensors' Q3FY16 results referenced by Travis Lundy Biosensors: Docs Out Deal Really On don't help any arguments for a higher valuation (nine month results):
Revenue -18% with product revenue -15% and licensing revenue -48%
Operating income -15% with across-the-board expense reductions mitigating the damage
Profit before exceptional items and charges -7% (mitigated by F/X gains and lower interest expense)
Fundamentally, the company continues to struggle with the usual intense competition with a…

Biosensors International

Updated Thoughts on Valuation